You are here

Photochemical Tissue Bonding for Military Medical Applications

Award Information
Agency: Department of Defense
Branch: Air Force
Contract: FA9550-09-C-0051
Agency Tracking Number: F074-033-0346
Amount: $574,397.00
Phase: Phase II
Program: STTR
Solicitation Topic Code: AF07-T033
Solicitation Number: N/A
Timeline
Solicitation Year: 2007
Award Year: 2009
Award Start Date (Proposal Award Date): 2008-10-28
Award End Date (Contract End Date): 2010-10-28
Small Business Information
5408 NE 88th Street, Bldg E
Vancouver, WA 98665
United States
DUNS: 799811646
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Dennis McCal
 Principal Engineer
 (503) 214-5331
 dennis.mccal@nlight.net
Business Contact
 Dan Milewski
Title: Sr. Financial Analyst
Phone: (360) 566-4479
Email: dan.milewski@nlight.net
Research Institution
 OMLC
 Scott Prahl
 
9205 SW Barnes Rd
Portland, OR 97225
United States

 (503) 216-2197
 Nonprofit College or University
Abstract

As described in our Phase I proposal: the overall goal is to develop a complete system for micro-anastomosis of blood vessels. This involves (1) a unique laser system that uses water as the absorbing chromophore, (2) a clinically useful handpiece that is appropriate for microsurgery, (3) a novel albumin stent to support the vessel during anastomosis, (4) in vitro testing of the device to assess thermal damage, strength, and operative time. And (5) In Vivo animal testing will be added to Phase II.  The Phase II effort will continue the work toward a system for blood vessel repair in an operating room environment using a thermally- stabilized 19xxnm laser with a green LED aiming beam. The goal is to provide a manufacturable laser system with a set of albumin stents of appropriate size for a range of blood vessel sizes and a surgical procedure for their use in repairing severed blood vessels and potentially other tissue repair.   BENEFIT: It is expected that the result of this phase will be laser units that can be further refined into a viable commercial laser for operating room use to repair blood vessels. It is further expected that a process for manufacture of albumin stents will be realized and that they will be available for use in developing this product to the point of FDA approval. It is also intended that the laser system developed will have broad applications and can be applied to other wavelength lasers and hand pieces as markets are addressed in future medical applications of nLIGHT lasers.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government